Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Hydroquinone vs Tazarotene: they're closely matched on evidence (7 vs 7.5/10); they're alternatives for even skin tone — the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Hydroquinone and Tazarotene are closely matched across evidence, studies, and safety.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (3)
Outcomes where both Hydroquinone and Tazarotene have evidence — compare verdict strength side-by-side.
Prescription topical. Hydroquinone is used at 2-4% (often as the triple-combination with a retinoid and a mild corticosteroid), applied to pigmented areas usually at night, in time-limited courses (commonly with treatment breaks) under clinician supervision, always with daily sunscreen. There is no oral or systemic use. Avoid indefinite continuous use because of ochronosis risk. This library does not provide an ingestion protocol.
Evening
Hydroquinone 2-4% cream or the triple-combination (with retinoid + mild steroid), under a clinician
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Evening
Tazarotene 0.045% lotion
Throughout
8-12 weeks
Throughout
Months to years
immediate
12 weeks
24 weeks
1-4 weeks
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Cutis (2003) · RCT · n=641
Two pooled 8-week multicenter randomized investigator-blind trials (n=641) of the triple-combination (tretinoin 0.05% + hydroquinone 4% + fluocinolone 0.01%) vs the three dual pairings
Efficacy and safety of a novel triple combination cream compared to Kligman's trio for melasma: A 24-week double-blind prospective randomized controlled trial.
J Eur Acad Dermatol Venereol (2023) · RCT · n=40
24-week double-blind RCT (n=40) using Kligman's trio (hydroquinone + retinoic acid + corticosteroid) as the active gold-standard comparator
Systematic review of randomized controlled trials on interventions for melasma: an abridged Cochrane review.
J Am Acad Dermatol (2014) · Systematic Review · n=2125
Abridged Cochrane review of 20 RCTs (2125 participants) across 23 melasma treatments
Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials
J Drugs Dermatol (2020) · RCT · n=1614
The two identical phase 3 registration trials for the 0.045% lotion — 1614 subjects aged 9 and older.
New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis
J Drugs Dermatol (2020) · RCT · n=684
A pooled paediatric SUBGROUP analysis of the two phase 3 trials, not a separate trial: 136 patients aged 10-13 and 548 aged 14-17.
Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial
Arch Dermatol (2002) · RCT · n=563
The long photodamage trial: 24 weeks double-blind, then a 28-week open-label extension — 12 months in total, 563 patients.
Both Hydroquinone and Tazarotene are closely matched — the best choice depends on your specific health goals.
For even skin tone, Hydroquinone has a higher relevance score (85 vs 70).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
AM/PM order, what to combine vs separate, and why sunscreen always comes first.
The depigmenter playbook (hydroquinone, azelaic, tranexamic, vitamin C) with sunscreen as the spine.
Commonly recommended vs ask-your-clinician vs avoid — a general, safety-first overview.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.